Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918

By sjmartinez • March 12, 2024

Wu Y, Sarkissyan M, Ogah O, Kim J, Vadgama JV. Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918. Cancers (Basel). 2024 Mar 1;16(5):1026. doi: 10.3390/cancers16051026. Erratum for: Cancers (Basel). 2020 Jul 16;12(7): PMID: 38473438.

Tags: Endocrinology, General Internal Medicine, King Drew Med Ctr, Publications

Related Posts

DDX20 is required for cell-cycle reentry of prospermatogonia and establishment of spermatogonial stem cell pool during testicular development in mice

Zou D, Li K, Su L, Liu J, Lu Y, Huang R, Li M, Mang X, Geng Q, Li P, Tang J, Yu Z, Zhang[...]

Author Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia

Koeberl D, Schulze A, Sondheimer N, Lipshutz GS, Geberhiwot T, Li L, Saini R, Luo J, Sikirica V, Jin L, Liang M, Leuchars M, Grunewald[...]

Time-to-Event Genome-Wide Association Study for Incident Cardiovascular Disease in People With Type 2 Diabetes

Kwak SH, Hernandez-Cancela RB, DiCorpo DA, Condon DE, Merino J, Wu P, Brody JA, Yao J, Guo X, Ahmadizar F, Meyer M, Sincan M, Mercader[...]